Aerovate Therapeutics Inc
NASDAQ:JBIO

Watchlist Manager
Aerovate Therapeutics Inc Logo
Aerovate Therapeutics Inc
NASDAQ:JBIO
Watchlist
Price: 10.51 USD 0.29% Market Closed
Market Cap: 9.7m USD

Intrinsic Value

The intrinsic value of one JBIO stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.51 USD, Aerovate Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

JBIO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Aerovate Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

JBIO looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if JBIO is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
Compare JBIO to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AVTE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Aerovate Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aerovate Therapeutics Inc

Current Assets 80.1m
Cash & Short-Term Investments 78.6m
Other Current Assets 1.5m
Non-Current Assets 215k
PP&E 215k
Efficiency

Free Cash Flow Analysis
Aerovate Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aerovate Therapeutics Inc

Revenue
0 USD
Operating Expenses
-74.3m USD
Operating Income
-74.3m USD
Other Expenses
4.7m USD
Net Income
-69.6m USD
Fundamental Scores

JBIO Profitability Score
Profitability Due Diligence

Aerovate Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Aerovate Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

JBIO Solvency Score
Solvency Due Diligence

Aerovate Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Aerovate Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JBIO Price Targets Summary
Aerovate Therapeutics Inc

Wall Street analysts forecast JBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JBIO is 18.36 USD with a low forecast of 17.17 USD and a high forecast of 19.95 USD.

Lowest
Price Target
17.17 USD
63% Upside
Average
Price Target
18.36 USD
75% Upside
Highest
Price Target
19.95 USD
90% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AVTE is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AVTE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one JBIO stock?

The intrinsic value of one JBIO stock under the Base Case scenario is hidden USD.

Is JBIO stock undervalued or overvalued?

Compared to the current market price of 10.51 USD, Aerovate Therapeutics Inc is hidden .

Back to Top